Birk Venture is the famous VC, which was founded in 2010. The fund was located in Europe if to be more exact in Norway. The main department of described VC is located in the Oslo.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Birk Venture, startups are often financed by Sarsia Seed Management. The meaningful sponsors for the fund in investment in the same round are Sarsia Seed Management, TeleVenture Management. In the next rounds fund is usually obtained by Investinor, Sarsia Seed Management, Trygve Schiorbeck.
We also calculated 1 valuable employee in our database.
The top activity for fund was in 2011. The top amount of exits for fund were in 2017. Speaking about the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. Comparing to the other companies, this Birk Venture performs on 0 percentage points less the average number of lead investments. Deals in the range of 1 - 5 millions dollars are the general things for fund.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Norway. The fund has exact preference in some founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight APIM Therapeutics, Targovax, BerGenBio. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Finance.
|Abac Capital||Barcelona, Catalonia, Spain|
|Blossom Street Ventures||Dallas, Texas, United States|
|DeltaPoint Capital Management||New York, Rochester, United States|
|fbFund||California, Palo Alto, United States|
|Frog Capital||England, London, United Kingdom|
|Hong Chang Biotechnology||China, Jiangsu, Suzhou|
|ICICI Prudential Mutual Fund||India, Maharashtra, Mumbai|
|Pof||British Columbia, Canada, Vancouver|
|Ren Quan Ventures||Beijing, Beijing, China|
|Shenzhen Yizan Investment Management||China, Guangdong, Shenzhen|
|Startia Holdings||Japan, Yamanashi, Yamanashi Prefecture|
|Stifel Nicolaus Canada Inc||Canada, Ontario, Toronto|
|Storage Technology Corp.||Colorado, Louisville, United States|
|Upshift Partners||California, San Francisco, United States|
|Venture Center||India, Maharashtra, Pune|
Accession Therapeutics Limited
|$22M||21 Nov 2022||Oxford, Oxfordshire, United Kingdom|
Accession Therapeutics Limited
|$15M||20 Sep 2021||Oxford, Oxfordshire, United Kingdom|
|01 Jan 2017||Oslo, Norway|
|17 Oct 2012||Trondheim, Trøndelag|
|$1M||01 Feb 2012||Oslo, Norway|
|10 Nov 2011||Trondheim, Trøndelag, Norway|
|$1M||02 Mar 2011||Bergen, Vestland|
|01 Jan 2010||Oslo, Norway|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.